INTRODUCTION
Benign pigmented lesions, such as solar lentigines and seborrheic keratoses, are among the most common dermatologic diagnoses for which patients seek treatments [1] . Standard treatments include cryotherapy, intense pulsed light (IPL), and various laser devices [2] [3] [4] [5] . Although cryotherapy is an antiquated treatment modality, it remains used by many healthcare practitioners due to its portability and low cost [6] . In the 1950s, Dr. Ray Allington first introduced the method of dipping cotton swabs into liquid nitrogen for the treatment of benign cutaneous lesions [7] . In 1968, Dr. Setrag Zacarian and Michael Bryne developed the first handheld self-pressurized cryosurgical device [7] , which set off a revolution in the treatment of benign skin lesions. Later, IPL and both ablative and non-ablative laser devices gained popularity as treatment modalities [5] . While cryotherapy and light/ laser devices have been shown to lighten or completely remove lesions, they may also result in dyschromia or significant post-procedural downtime [4, 5] . Therefore, we present early clinical experience with a novel Dermal Cooling System that provides localized, controlled freezing to benign pigmented lesions.
MATERIALS AND METHODS
Twenty patients at the laser and cosmetic dermatology clinic at the University of California, San Diego, were consented for treatment with the Dermal Cooling System for benign pigmented lesions. Patients were informed of other available treatment modalities, including cryotherapy, IPL, and various laser devices.
The handpiece of the Dermal Cooling System delivered controlled and precise freezing for the treatment of benign pigmented lesions. The treatment protocol included applying a mask to confine freezing to discrete lesions and a hydrated interface between the skin and the handpiece applicator. The device was configured to provide 107-166 kJ/m 2 of extracted energy. Treatment parameters were selected upon lesion type, anatomical location, and Fitzpatrick skin type. Treatment exposure times ranged from 0 to 15 seconds freeze cycles. Cycles ranged from 1 to 3 within each treatment session.
Baseline and 1-month post-treatment photographs were reviewed and graded by two blinded investigators (A.N. and A.G.). Photographs were graded on a four-point improvement scale compared to baseline ( 
. Scores were then averaged between reviewers.
System. Fifteen patients returned for follow-up photos of their first treatment, and five patients received additional treatment. In order of frequency, treated lesions included solar lentigines (n ¼ 6), early seborrheic keratoses (n ¼ 5), melasma (n ¼ 2), post-inflammatory hyperpigmentation (n ¼ 1), and a case of Hori's nevus (n ¼ 1). The two blinded investigators rated the clinical improvement with average scores of 1.7 (26-50% improvement compared to baseline) at 1 month after one treatment, 2.4 (26-50% improvement compared to baseline) at 1 month after the second treatment, and 3.0 (51-75% improvement compared to baseline) at 1 month after the third treatment (Fig. 1) . Greatest clinical improvement was seen in macular lesions or slightly raised lesions (Figs. 2 and 3 ). Of note, two patients had complete clearance of solar lentigines after a single treatment.
Treatment side effects included transient erythema, swelling, itching, and darkening. Patients reported that all side effects resolved within 3 days. Transient darkening was noted at 1-month follow-up for a subject with Fitzpatrick skin type IV treated for facial postinflammatory hyperpigmentation. However, significant lightening of hyperpigmentation compared to baseline was seen at 3-month follow-up with 26-50% improvement per both blinded reviewers.
DISCUSSION
Treatment with the Dermal Cooling System was shown to be well-tolerated and effective, with the greatest results seen in macular or very slightly raised lesions. Unlike conventional cryotherapy, the Dermal Cooling System allows the practitioner to deliver precise and controlled treatment in the absence of long-term side effects, such as long-term dyspigmentation, blistering, or scarring. Lower treatment settings resulted in essentially no downtime, while higher settings decreased the number of treatments necessary with minimal downtime. Conventional cryotherapy with tissue temperatures of À20 to À308C causes rapid tissue freezing via formation of intra-and extracellular ice crystals, which ultimately disrupts and destroys cells [5] . However, studies have shown that benign pigmented lesions treated with liquid nitrogen develop hypopigmentation of the surrounding normal skin and hyperpigmentation of the lesion itself lasting six months or more [4] . Severe adverse effects associated with cryotherapy, such as pain, blistering, bleeding, and hypertrophic scarring [5] , were not observed with the Dermal Cooling System. Similar to cryotherapy, the advent of intense pulse light and laser technologies has enabled practitioners to specifically and effectively treat benign pigmented lesions; however, patients may experience prolonged erythema and downtime lasting days to weeks [8] . The Dermal Cooling System provides treatments that are able to be customized to patient's needs in order to balance the minimum number of treatment sessions with duration of downtime. The control and flexibility of treatment administration provides patients the option to undergo treatment sessions with virtually no erythema or downtime.
CONCLUSION
Although multiple modalities are available, a need still persists to address the prevalence of benign pigmented lesions combined with patient's desire for effective treatments without social downtime. The novel Dermal Cooling System shows promise in the treatment of macular to slightly raised benign pigmented lesions with virtually no erythema or downtime. Further clinical experience is necessary to optimize treatment parameters and determine which lesions respond best. 
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